BioSpace News Archive

The FDA said the companies marketed the herbal extract with unproven claims. Kratom has not been approved by the FDA for any use.

Atomwise invented a deep learning artificial intelligence technology for structure-based small molecule drug discovery. Enamine is the world’s largest chemical supplier.

Biotech and pharma companies from across the globe share pipeline and business updates.

Medidata announced that global pharmaceutical company Orion will consolidate all clinical trials on the Medidata Rave Clinical Cloud™ and expand its use of trial management solutions to support growth of its R&D pipeline.

Osaka Medical College, Fukui Tateami Co., Ltd. and Teijin Limited announced that the alliance has launched a clinical trial of their newly developed patch material, OFT-G1, for cardiovascular surgery and the first surgery using the OFT-G1 was successfully performed.

Lead indication for spinal cord injury continues to advance to phase one clinical trial

Esperion and an investor group led by Oberland Capital Management LLC announced a $200 million capped, tiered, revenue-based funding agreement on net revenues of bempedoic acid and the bempedoic acid / ezetimibe combination tablet.

BioTek’s Synergy™ Neo2 Hybrid Multi-Mode Microplate Reader received expanded certification from Cisbio Bioassays for their proprietary HTRF® technology, a TR-FRET assay platform used in the Life Sciences.

Frontier Medicines has announced the closing of a Series A Preferred Stock financing round of $67 million led by Deerfield Management, Droia Oncology Ventures and MPM Capital, with participation from DCVC Bio (an affiliated fund of DCVC), RA Capital Management and other investors, as detailed in the company’s press releas

Humira generates about 60% of AbbVie’s annual revenue but is expected to lose patent protection in 2023.